evidencegaps
Primary study · included by 1 review

Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: in situ and ex vivo 3.0 T MRI assessment.

Zhao 2024 · Zhao Lijun, Zhu Xiangzhi, Jiang Ning, et al. · The British journal of surgery · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Zhao 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.